trifluoperazine will improve the stage or influence of zolpidem by pharmacodynamic synergism. Modify Therapy/Observe Intently. Additive outcome of lessened alertness and psychomotor overall performanceIn addition, fluvoxamine (a robust inhibitor of CYP1A2 as well as a weak inhibitor of CYP3A4 and CYP2C9) and ciprofloxacin (a solid inhibitor of CYP1